Literature DB >> 15448503

Scleral ulceration caused by Cryptococcus albidus in a patient with acquired immune deficiency syndrome.

Jordan M Garelick1, A James Khodabakhsh, Yineth Lopez, Mahrukh Bamji, Mark Lister.   

Abstract

PURPOSE: To describe a case of a scleral ulceration caused by Cryptococcus albidus in a patient with acquired immune deficiency syndrome (AIDS).
DESIGN: Interventional case report. A 16-year-old girl with AIDS was admitted to the hospital with a 1-week history of cough, fever, and sudden onset of a painless scleral lesion on her left eye. Culture of the lesion revealed the fungus Crypotococcus albidus.
RESULTS: The patient was treated with topical amphotericin B and systemic itraconazole, and she recovered fully over 4 weeks without sequelae.
CONCLUSION: Cryptococcus albidus rarely causes disease in humans. It should be considered as a potential cause of ocular and systemic disease in patients with AIDS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15448503     DOI: 10.1097/01.ico.0000126322.13143.7b

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  12 in total

1.  False-positive culture results from patient tissue specimens due to contamination of RPMI medium with Cryptococcus albidus.

Authors:  Lisa G Winston; Marguerite Roemer; Carol Goodman; Barbara Haller
Journal:  J Clin Microbiol       Date:  2007-02-21       Impact factor: 5.948

Review 2.  Case Report of Cryptococcus Albidus Peritonitis in a Peritoneal Dialysis Patient and a Review of the Literature.

Authors:  Loheetha Ragupathi; Maria Reyna
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

3.  Multidrug resistant yeasts in synanthropic wild birds.

Authors:  Alexander Tiong Kah Lord; Kavitha Mohandas; Sushela Somanath; Stephen Ambu
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-03-23       Impact factor: 3.944

4.  Evaluation of the experimental inoculation of Cryptococcus albidus and Cryptococcus laurentii in normal mice: virulence factors and molecular profile before and after animal passage.

Authors:  Reginaldo dos Santos Pedroso; Joseane Cristina Ferreira; Marco Aurélio Sicchiroli Lavrador; Claudia Maria Leite Maffei; Regina Celia Candido
Journal:  Mycopathologia       Date:  2009-04-11       Impact factor: 2.574

5.  Capsules from pathogenic and non-pathogenic Cryptococcus spp. manifest significant differences in structure and ability to protect against phagocytic cells.

Authors:  Glauber de S Araujo; Fernanda L Fonseca; Bruno Pontes; Andre Torres; Radames J B Cordero; Rosely M Zancopé-Oliveira; Arturo Casadevall; Nathan B Viana; Leonardo Nimrichter; Marcio L Rodrigues; Eloi S Garcia; Wanderley de Souza; Susana Frases
Journal:  PLoS One       Date:  2012-01-12       Impact factor: 3.240

6.  Cryptococcus albidus encephalitis in newly diagnosed HIV-patient and literature review.

Authors:  Yang Liu; Shaolin Ma; Xuebin Wang; Wei Xu; Jin Tang
Journal:  Med Mycol Case Rep       Date:  2013-11-23

7.  First case of superficial infection due to Naganishia albida (formerly Cryptococcus albidus) in Iran: A review of the literature.

Authors:  S Aghaei Gharehbolagh; M Nasimi; S Agha Kuchak Afshari; Z Ghasemi; S Rezaie
Journal:  Curr Med Mycol       Date:  2017-06

Review 8.  Anterior segment manifestations of human immunodeficiency virus/acquired immune deficiency syndrome.

Authors:  Jyotirmay Biswas; S Sudharshan
Journal:  Indian J Ophthalmol       Date:  2008 Sep-Oct       Impact factor: 1.848

9.  Candida albicans scleral abscess in a HIV-positive patient and its successful resolution with antifungal therapy-a first case report.

Authors:  Hitesh Sharma; Sridharan Sudharshan; Lily Therese; Mamta Agarwal; Jyotirmay Biswas
Journal:  J Ophthalmic Inflamm Infect       Date:  2016-05-20

10.  Candida albicans scleral abscess in a HIV-positive patient and its successful resolution with antifungal therapy-a first case report.

Authors:  Hitesh Sharma; Sridharan Sudharshan; Lily Therese; Mamta Agarwal; Jyotirmay Biswas
Journal:  J Ophthalmic Inflamm Infect       Date:  2016-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.